BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33889569)

  • 1. The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation.
    Huang X; Wang B; Chen R; Zhong S; Gao F; Zhang Y; Niu Y; Li C; Shi G
    Front Cell Dev Biol; 2021; 9():583146. PubMed ID: 33889569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesoid X receptor functions in cervical cancer via the p14
    Huang X; Wang B; Shen H; Huang D; Shi G
    Mol Biol Rep; 2022 May; 49(5):3617-3625. PubMed ID: 35347542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of FXR promotes intestinal metaplasia of gastric cells via SHP-dependent upregulation of the expression of CDX2.
    Zhou H; Ni Z; Li T; Su L; Zhang L; Liu N; Shi Y
    Oncol Lett; 2018 May; 15(5):7617-7624. PubMed ID: 29849798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
    Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
    Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM47 silencing inhibits the malignant biological behaviors of prostate cancer cells by regulating MDM2/p53 signaling.
    Wang C; Chang R; Li J; Li L
    Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38802602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells.
    Wu B; Xing C; Tao J
    J Orthop Surg Res; 2019 Nov; 14(1):398. PubMed ID: 31779647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
    Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
    Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
    Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
    J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
    Pu Q; Lv YR; Dong K; Geng WW; Gao HD
    BMC Cancer; 2020 Jun; 20(1):583. PubMed ID: 32571254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 inhibition-mediated autophagy contributes to the pro-apoptotic effect of berberine in p53-null leukemic cells.
    Liu J; Zhu Z; Liu Y; Wei L; Li B; Mao F; Zhang J; Wang Y; Liu Y
    Life Sci; 2020 Feb; 242():117228. PubMed ID: 31881227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor inhibits LNcaP cell proliferation via the upregulation of PTEN.
    Liu J; Tong SJ; Wang X; Qu LX
    Exp Ther Med; 2014 Oct; 8(4):1209-1212. PubMed ID: 25187826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells.
    Barzalobre-Gerónimo R; Flores-López LA; Baiza-Gutman LA; Cruz M; García-Macedo R; Ávalos-Rodríguez A; Contreras-Ramos A; Díaz-Flores A; Ortega-Camarillo C
    Mol Cell Biochem; 2015 Jul; 405(1-2):257-64. PubMed ID: 25912675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
    Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
    Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
    Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
    Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia/reperfusion injury in mice.
    Gao Y; Zhao Y; Yuan A; Xu L; Huang X; Su Y; Gao L; Ji Q; Pu J; He B
    Exp Cell Res; 2018 Oct; 371(2):301-310. PubMed ID: 30098335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.